Literature DB >> 9059169

Biphosphonates.

J Allgrove1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059169      PMCID: PMC1717046          DOI: 10.1136/adc.76.1.73

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  27 in total

1.  Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.

Authors:  H D McIntyre; D P Cameron; S M Urquhart; W E Davies
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

2.  Is APD a promising drug in the treatment of severe osteogenesis imperfecta?

Authors:  J P Huaux; W Lokietek
Journal:  J Pediatr Orthop       Date:  1988 Jan-Feb       Impact factor: 2.324

3.  Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva.

Authors:  J G Rogers; J P Dorst; W B Geho
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

4.  Diphosphonates in the treatment of myositis ossificans.

Authors:  C A Bassett; A Donath; F Macagno; R Preisig; H Fleisch; M D Francis
Journal:  Lancet       Date:  1969-10-18       Impact factor: 79.321

5.  Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate.

Authors:  H I Harinck; O L Bijvoet; J W van der Meer; B Jones; G J Onvlee
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

6.  Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate.

Authors:  B R Boudailliez; B J Pautard; J L Sebert; O Kremp; C X Piussan
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

7.  Idiopathic infantile arterial calcification: unusual features.

Authors:  J Vera; J Lucaya; J A Garcia Conesa; C Aso; A Balaguer
Journal:  Pediatr Radiol       Date:  1990

8.  Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta.

Authors:  J P Devogelaer; J Malghem; B Maldague; C Nagant de Deuxchaisnes
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

9.  Idiopathic infantile arterial calcification in siblings: radiologic diagnosis and successful treatment.

Authors:  M Meradji; V H de Villeneuve; J Huber; W C de Bruijn; R G Pearse
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

10.  Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis.

Authors:  K Hoekman; S E Papapoulos; A C Peters; O L Bijvoet
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

View more
  13 in total

1.  Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.

Authors:  Eva Aström; Håkan Jorulf; Stefan Söderhäll
Journal:  Arch Dis Child       Date:  2006-11-17       Impact factor: 3.791

Review 2.  Bone mineral accrual and low bone mass: a pediatric perspective.

Authors:  Inessa M Gelfand; Linda A DiMeglio
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  Pamidronate treatment improves bone mineral density in children with Menkes disease.

Authors:  S Kanumakala; A Boneh; M Zacharin
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  Intravenous pamidronate in juvenile osteoporosis.

Authors:  N J Shaw; C M Boivin; N J Crabtree
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 5.  Bisphosphonate treatment of bone disease.

Authors:  N J Shaw; N J Bishop
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

Review 6.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

7.  Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.

Authors:  A M Boot; J Bouquet; E P Krenning; S M de Muinck Keizer-Schrama
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

8.  Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.

Authors:  E Aström; S Söderhäll
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

9.  SAPHO Syndrome Diagnosis and Treatment: Report of Five Cases and Review of the Literature.

Authors:  Ch Matzaroglou; D Velissaris; A Karageorgos; M Marangos; E Panagiotopoulos; M Karanikolas
Journal:  Open Orthop J       Date:  2009-11-05

10.  Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases.

Authors:  Joao L Fernandes; Sergio L Viana; Arthemizio L Rocha; Maria C Ribeiro; Luis C Castro
Journal:  Skeletal Radiol       Date:  2004-08-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.